Literature DB >> 24284825

Pyroglutamylated RF-amide peptide (QRFP) gene is regulated by metabolic endotoxemia.

Christian Jossart1, Mukandila Mulumba, Riccarda Granata, Davide Gallo, Ezio Ghigo, Sylvie Marleau, Marc J Servant, Huy Ong.   

Abstract

Pyroglutamylated RF-amide peptide (QRFP) is involved in the regulation of food intake, thermogenesis, adipogenesis, and lipolysis. The expression of QRFP in adipose tissue is reduced in diet-induced obesity, a mouse model in which plasma concentrations of endotoxins are slightly elevated. The present study investigated the role of metabolic endotoxemia (ME) on QRFP gene regulation. Our results uncovered the expression of QRFP in murine macrophages and cell lines. This expression has been found to be decreased in mice with ME. Low doses of lipopolysaccharide (LPS) transiently down-regulated QRFP by 59% in RAW264.7 macrophages but not in 3T3-L1 adipocytes. The effect of LPS on QRFP expression in macrophages was dependent on the inhibitor of kB kinase and TIR-domain-containing adapter-inducing interferon (IFN)-β (TRIF) but not myeloid differentiation primary response gene 88. IFN-β was induced by ME in macrophages. IFN-β sustainably reduced QRFP expression in macrophages (64%) and adipocytes (49%). IFN-γ down-regulated QRFP (74%) in macrophages only. Both IFNs inhibited QRFP secretion from macrophages. LPS-stimulated macrophage-conditioned medium reduced QRFP expression in adipocytes, an effect blocked by IFN-β neutralizing antibody. The effect of IFN-β on QRFP expression was dependent on phosphoinositide 3-kinase, p38 MAPK, and histone deacetylases. The effect of IFN-γ was dependent on MAPK/ERK kinase 1/2 and histone deacetylases. Macrophage-conditioned medium containing increased amounts of QRFP preserved adipogenesis in adipocytes. In conclusion, LPS induces IFN-β release from macrophages, which reduces QRFP expression in both macrophages and adipocytes in an autocrine/paracrine-dependent manner, suggesting QRFP as a potential biomarker in ME.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24284825      PMCID: PMC5426650          DOI: 10.1210/me.2013-1027

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  60 in total

1.  GPR103b functions in the peripheral regulation of adipogenesis.

Authors:  Mukandila Mulumba; Christian Jossart; Riccarda Granata; Davide Gallo; Emanuel Escher; Ezio Ghigo; Marc J Servant; Sylvie Marleau; Huy Ong
Journal:  Mol Endocrinol       Date:  2010-06-09

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Mechanisms of mRNA translation of interferon stimulated genes.

Authors:  Sonali Joshi; Surinder Kaur; Barbara Kroczynska; Leonidas C Platanias
Journal:  Cytokine       Date:  2010-04-20       Impact factor: 3.861

4.  Transcriptional control of adipose lipid handling by IRF4.

Authors:  Jun Eguchi; Xun Wang; Songtao Yu; Erin E Kershaw; Patricia C Chiu; Joanne Dushay; Jennifer L Estall; Ulf Klein; Eleftheria Maratos-Flier; Evan D Rosen
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

5.  26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas.

Authors:  Eva M Egido; Raquel Hernández; Jérôme Leprince; Nicolas Chartrel; Hubert Vaudry; José Marco; Ramona A Silvestre
Journal:  Peptides       Date:  2006-06-13       Impact factor: 3.750

6.  Anti-allodynic effects of intrathecally and intracerebroventricularly administered 26RFa, an intrinsic agonist for GRP103, in the rat partial sciatic nerve ligation model.

Authors:  Tatsuo Yamamoto; Rika Miyazaki; Toshihiko Yamada; Tomonari Shinozaki
Journal:  Peptides       Date:  2011-03-23       Impact factor: 3.750

Review 7.  Adipose tissue recruitment of leukocytes.

Authors:  Emily K Anderson; Dario A Gutierrez; Alyssa H Hasty
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

8.  Novel role of 26RFa, a hypothalamic RFamide orexigenic peptide, as putative regulator of the gonadotropic axis.

Authors:  V M Navarro; R Fernández-Fernández; R Nogueiras; E Vigo; S Tovar; N Chartrel; O Le Marec; J Leprince; E Aguilar; L Pinilla; C Dieguez; H Vaudry; M Tena-Sempere
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

9.  Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.

Authors:  Khadija Elhabazi; Jean-Paul Humbert; Isabelle Bertin; Martine Schmitt; Frédéric Bihel; Jean-Jacques Bourguignon; Bernard Bucher; Jérôme A J Becker; Tania Sorg; Hamid Meziane; Benoit Petit-Demoulière; Brigitte Ilien; Frédéric Simonin
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

10.  Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism.

Authors:  Antonio Castrillo; Sean B Joseph; Sagar A Vaidya; Margaret Haberland; Alan M Fogelman; Genhong Cheng; Peter Tontonoz
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

View more
  2 in total

Review 1.  The Arg-Phe-amide peptide 26RFa/glutamine RF-amide peptide and its receptor: IUPHAR Review 24.

Authors:  Jérôme Leprince; Didier Bagnol; Ronan Bureau; Shoji Fukusumi; Riccarda Granata; Shuji Hinuma; Dan Larhammar; Stefany Primeaux; Jana Sopkova-de Oliveiras Santos; Kazuyoshi Tsutsui; Kazuyoshi Ukena; Hubert Vaudry
Journal:  Br J Pharmacol       Date:  2017-09-08       Impact factor: 8.739

Review 2.  Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function.

Authors:  Iacopo Gesmundo; Tania Villanova; Dana Banfi; Giacomo Gamba; Riccarda Granata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-03       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.